ArticleProbiotics and antimicrobial proteins2026
Multifactorial Neuroprotective Potential of γ-Aminobutyric acid-Producing Potential Probiotics Against Stress Induced Neuronal Cell Lines.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characteristics of gut microbiota dysbiosis in patients with depression: a visual analysis of knowledge maps.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gamma-aminobutyric acid (GABA) is associated with depressive-like behaviours and influences the gut-brain axis through vagal nerve-dependent mechanisms. Studies indicate that depression can be reversed with GABA administration, but the neuroprotective potential of GABA-producing bacteria remains underexplored. Subtractive screening identified five potential GABA-producing strains out of 95 distinct isolates, which were subsequently confirmed using thin-layer chromatography, NMR, and mass spectrometry. All five strains survived in acidic conditions, with survivability rates of 72-84%, and in 0.3% bile, with survivability rates of 93-96%. The selected strains showed higher hydrophobicity to chloroform, possessed free radical scavenging activities, and were capable of forming stronger biofilms. This study identifies Limosilactobacillus fermentum PB02 and Levilactobacillus brevis MM as potential GABA-producing probiotics. The neuroprotective effects of GABA-containing cell-free supernatant (CFS) were tested in stress-challenged Human Neuroblastoma SH-SY5Y cell lines. The CFS supplementation increased cell viability after exposure to high glucose and lipopolysaccharide, and improved viability in a glutamate-induced excitotoxicity assay, indicating the multifactorial in vitro neuroprotective potential. This study enhanced the viability of cells by 20-25% viability in cells challenged with 250mM glucose and 1 µg/mL LPS, and in the glutamate-mediated excitotoxicity assay. Additionally, L. fermentum PB02 and L. brevis MM emerged as promising psychobiotic candidates with neuroprotective effects, as indicated by Principal Component Analysis and weighted scoring matrix analysis. By integrating clustering analysis, we demonstrate that isolated strains can be promising candidates showing neuroprotective potential using in vitro methods. Further in vivo validation will be required to confirm these effects.
Indexed as
Identifiers
41697617What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.